Latest News
July 26, 2021
BlueRock Therapeutics Announces New Board Chair, New President and CEO
July 26, 2021
Bayer announces Prof. Dr. Dominik Ruettinger as new Head of Research and Early Development for Oncology
July 21, 2021
Not intended for U.S. and UK Media
Bayer’s new symptomatic chronic heart failure treatment Verquvo™ (vericiguat) approved in EU
July 19, 2021
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson’s Disease
July 09, 2021
Not intended for U.S. and UK Media
U.S. FDA approves finerenone for the treatment of patients with chronic kidney disease associated with type 2 diabetes
Global Health Policy Blog
Current Topics